跳至主要内容
临床试验/NCT06261606
NCT06261606Unknown不适用

Feasibility of a Multifaceted Intervention to Mitigate the Cardiovascular Adverse Effects of Air Pollution: The COATED-AIR Feasibility Trial

Parham Sadeghipour1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年1月28日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
50
试验地点
1
主要终点
Feasibility of conducting the trial

研究概览

简要总结

The main goal of this clinical trial is to evaluate the feasibility of conducting a large-scale clinical trial testing a program containing several aspects for reducing the effects of air pollution on cardiovascular health (which is named the hybrid program hereafter) in adult patients (18 years or older) with atherosclerotic cardiovascular disease. Furthermore, we seek to answer how much patients adhere to and are satisfied with implementing the hybrid program, and what problems executing this program will bring for patients.

详细描述

Background:

Air pollution, as the fourth leading cause of mortality globally, is annually responsible for 6.67 million deaths worldwide and approximately half of them are attributable to cardiovascular causes. Some of the pollutants can negatively affect the cardiovascular system, as they may pass through the lungs, entering into the bloodstream, and cause inflammation and oxidative stress. Exposure to these pollutants is associated with a diverse range of fatal and/or adverse non-fatal cardiovascular events, including myocardial infarction, heart failure, atrial fibrillation, and ischemic stroke.

Besides strategies in societal-level aiming to control the air pollution, various individual-level solutions have been suggested to mitigate the health-related effects of air pollution. Text messaging via mobile phones to alert individuals about unhealthy air quality levels, and recommending to limit activity and time spent in outdoors, use face mask when going out, or use air filtration systems are among these individual-level solutions to restrict the air pollution-related health effects. Furthermore, several studies have proposed dietary interventions and demonstrated that some nutrients, especially vitamins C and E, are potentially capable to counter with the adverse effects of air pollutants on the cardiovascular system. However, the efficacy of these individual-level solutions to reduce the the incidence of clinically relevant outcomes such as myocardial infarction, stroke, and acute limb events.

The current pilot randomized controlled trial (RCT) seeks to test the feasibility and adherence of patients with atherosclerotic cardiovascular diseases (ASCVD) to a multifaceted intervention including a one-page informational flashcard, cell phone message alerting on days with poor air quality to encourage patients not to spend time outdoors, or to wearing KN-95 facemasks outdoors in those days, and encouraging patients to consume citrus fruits on highly polluted days (which is hereafter referred to as hybrid strategy).

Randomization Procedure:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adult patients (≥18 years) with documented ASCVD defined as at least one of the following:
  • •Coronary artery disease (CAD):
  • •Previous or recent documented type I myocardial infarction
  • •History of coronary revascularization (percutaneous coronary intervention or coronary artery bypass graft surgery)
  • •History of obstructive CAD (>50% stenosis) documented by coronary computed tomography (CT) or conventional angiography
  • •Peripheral arterial disease (PAD):
  • •Previous or recent acute ischemic limb event (>7 days prior)
  • •History of previous endovascular/surgical lower or upper extremities revascularization for an atherosclerotic cause
  • •History of ulcer or lower extremities amputation due to ASCVD.
  • •Carotid arterial diseases:
  • •History of previous endovascular/surgical carotid artery revascularization for atherosclerotic cause
  • •History of > 50% carotid artery stenosis based on documented imaging tests (Duplex ultrasonography, CT angiography, magnetic resonance angiography, or conventional angiography)
  • •Ischemic stroke:
  • •History of recent or previous documented ischemic stroke not due to systemic hypoperfusion/hypotension being treated with low-dose aspirin
  • •Willing to participate and able to provide written informed consent

排除标准

  • •Being within 7 days of acute/unstable ASCVD events (acute myocardial infarction, acute limb event, and acute ischemic stroke) or receiving triple antithrombotic therapy
  • •Active bleeding
  • •History of upper gastrointestinal bleeding within the past 30 days
  • •History of intracranial hemorrhage within the past 30 days
  • •End-stage kidney disease with estimated creatinine clearance < 15 mL/min, or undergoing hemodialysis or peritoneal dialysis
  • •Known aspirin sensitivity without prior successful desensitization
  • •Known comorbidities associated with poor prognosis (e.g., metastatic cancer) in conjunction with an estimated life expectancy of less than one year according to the treating clinician
  • •Vascular disease known exclusively to be from causes other than atherosclerosis (spontaneous coronary or peripheral dissection (fibromuscular dysplasia, segmental arterial mediolysis) or vasculitis such as Takayasu arteritis, Buerger's disease (i.e., thromboangiitis obliterans), and Churg Strauss syndrome
  • •Inherited or acquired severe coagulopathies including hemophilia and decompensated liver cirrhosis
  • •Any other unexpected/unwarranted conditions that make the participants unsuitable for recruitment or follow-up
  • •Known allergy to KN-95 or other masks, or citrus fruits
  • •Any facial dysmorphia that makes the patient unable or unwilling to wear a face mask
  • •Any medical condition necessitating unblinded facemask use for outdoor activities at the discretion of the treating clinician, or based on patient preference
  • •Inability to receive/read text messages/phone calls by personal mobile phone
  • •Unwillingness to participate, such as hesitation to wear a mask, if randomized

研究组 & 干预措施

Hybrid strategy

Experimental

A hybrid strategy inclusive of:

  1. A one-page flashcard describing the adverse cardiovascular effects of air pollution and individual-level strategies to mitigate these effects
  2. Alerting patients on polluted days (defined as air quality index (AQI) ≥ 131 [33]) by sending cell phone text messages and recommending to not go outdoors or minimize outdoor activities (especially exercising) on those days. This will also be accompanied by periodic phone calls to ascertain that the patients receive the messages and are attentive to them.
  3. Wearing KN-95 facemasks (provided by the investigators of this study) as a physical barrier against air pollution on highly polluted days (defined as AQI ≥ 131) in case the patient cannot avoid going outdoors
  4. Dietary intervention by encouraging patients to consume citrus fruits during days with AQI ≥ 131.

干预措施: Hybrid strategy (Other)

Usual care

No Intervention

No active strategy (usual care) without any clear recommendations related to air pollution. A control card will be shared with the patients randomized to the control group

结局指标

主要结局

Feasibility of conducting the trial

时间窗: within 30 days

Recruitment rate defined as the proportion of participants randomized divided by the proportion of eligible participants

次要结局

  • Patient satisfaction with the hybrid strategy(within 30 days)
  • Adherence to the individual components of the hybrid strategy(within 30 days)
  • Any potential adverse events in intervention and control groups during the 30-day follow-up(within 30 days)

研究者

发起方
Parham Sadeghipour
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Parham Sadeghipour

Associate professor

Rajaie Cardiovascular Medical and Research Center

研究点 (1)

Loading locations...

相似试验

Feasibility of a Multifaceted Program to Reduce... | 临床试验